News

cf.png

CoreFlow® - Soft Stent launched in Sweden

CoreFlow® - Soft Stent - an innovative product with multiple functions

BUSINESS IDEA

ProstaLund will offer patients with benign prostate enlargement an individually tailored, non-surgical treatment that is potent, safe, painless and cost-effective.

FINANCIAL REPORTS

 

Year-end report January-December 2020 published

PRESS RELEASES

Johan Wennerholm appointed CEO of ProstaLund AB

About us

ProstaLund is a Swedish medtech company, a leader in the development of innovative products and treatments in urology. ProstaLund has patented CoreTherm®, an individualized thermotherapy treatment for benign prostatic hyperplasia (Benign Prostatic Hyperplasia - BPH). CoreTherm® is used today in hospitals and outpatient clinics in Sweden and around the world.

Read more about ProstaLund's new product CoreFlow® - Soft Stent

Prostalund AB includes the subsidiary Nordisk Medicin & Teknik AB. The company provides innovative and cost-effective products with good quality to simplify work in healthcare in the Nordic region.

Contact Us

ProstaLund AB

Scheelevägen 19

SE-22363 Lund

info@prostalund.com

Tel: +46 46-12 09 08

Thank you, your message has been sent!